Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?

BACKGROUND: It is highly contested whether cytoreductive nephrectomy for treating advanced renal cell carcinoma (RCC) with sarcomatoid features (sRCC) benefits overall survival. Patients with sRCC are known to have a poor prognosis, and these tumors have a more aggressive biology than those without...

Descripción completa

Detalles Bibliográficos
Autores principales: Adashek, Jacob J., Zhang, Yumeng, Skelton, William Paul, Bilotta, Alyssa, Chahoud, Jad, Zemp, Logan, Li, Jiannong, Dhillon, Jasreman, Manley, Brandon, Spiess, Philippe E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902859/
https://www.ncbi.nlm.nih.gov/pubmed/33643921
http://dx.doi.org/10.3389/fonc.2020.627025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902859/
https://www.ncbi.nlm.nih.gov/pubmed/33643921
http://dx.doi.org/10.3389/fonc.2020.627025

Ejemplares similares